November 22, 2013UCCCC Investigators Use Genomics to Unravel the Complexities of Pancreatic Cancer
There are not too many success stories in pancreatic cancer. But a multi-investigator team at the University of Chicago Medicine Comprehensive Cancer Center is trying to change this bleak outlook.
November 13, 2013Immaculate Reception: Breast Cancer Mutations Tackle Hormone Blockers
First, scientists developed a way to thwart breast cancer by blocking the estrogen receptor. Then breast cancer evolved a way to thwart scientists. Geffrey Green, chair of the Ben May Department of Cancer Research, and his team may have discovered why.
October 18, 2013In Patients with Ulcerative Colitis, Inflammation Ups Cancer Risk
Although persistent inflammation has long been associated with colon cancer in patients with ulcerative colitis, a large study by University of Chicago Medicine’s David Rubin, MD, has confirmed the link between the severity and duration of inflammation and increased colorectal cancer risk.
October 3, 2013Supermicrosurgery: A New Way to Open Clogged Drains
The University of Chicago Medicine recently recruited pioneer surgeon David Chang, MD, FACS, to bring complex microsurgery, called lymphaticovenular bypass, to help breast cancer patients who develop lymphedema.
August 21, 2013A Computerized Hunt for Cancer Classifiers
Finding a better way to fight cancer doesn’t always mean discovering a new drug or surgical technique. It can mean a more specific diagnosis that uses applied informatics to discover gene combinations that can point to more effective treatments.
Recent Posts by UChicago Cancer Experts
The premier event of the year dedicated to the causes and treatments of blood disorders is expected to draw more than 18,000 hematologists and other healthcare professionals from all 50 states and nearly 100 countries. University of Chicago experts will be presenting papers and posters this weekend on a variety of Hem/Onc-related topics.
Richard Edelman spent Thanksgiving going through the apartment of his late parents in Chicago, sorting through old letters and packing up clothes to donate to charity. He’s dedicating GivingTuesday to “my friends at the University of Chicago Medical Center, specifically Dr. Wendy Stock, Dr. John Kress and Dr. Jesse Hall, whose dedication to their profession and kindness to my parents will never be forgotten.”
Despite tremendous advances in cancer care, lung cancer remains one of the deadliest forms of cancer in the world. Our early adoption of minimally invasive robotic surgical techniques drives new opportunities to treat complex lung cancer cases.
The lack of buzz surrounding Lung Cancer Awareness month is perplexing since lung cancer is the leading cause of cancer death in the U.S.. It’s especially perplexing to Meghan O’Brien who has stage 4 lung cancer, and her oncologist, Ravi Salgia, MD, PhD, of the University of Chicago Medicine.
Responses to chemotherapy and other drugs can vary dramatically from patient to patient. But efforts to implement pharmacogenomc testing into routine clinical practice may help predict the responses to commonly prescribed medications in the future.